Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal

被引:15
|
作者
Meisel, Andreas [1 ]
Baggi, Fulvio [2 ]
Behin, Anthony [3 ]
Evoli, Amelia [4 ,5 ]
Kostera-Pruszczyk, Anna [6 ]
Mantegazza, Renato [2 ]
Morales, Raul Juntas [7 ]
Punga, Anna Rostedt [8 ]
Sacconi, Sabrina [9 ]
Schroeter, Michael [10 ]
Verschuuren, Jan [11 ]
Crathorne, Louise [12 ]
Holmes, Kris [12 ]
Leite, Maria-Isabel [13 ]
机构
[1] Charite Univ Med Berlin, NeuroCure Clin Res Ctr, Integrated Myasthenia Gravis Ctr, Dept Neurol, Berlin, Germany
[2] Fdn Carlo Besta Neurol Inst, Neuroimmunol & Neuromuscular Dis Unit, Sci Inst Res & Hlth Care, Milan, Italy
[3] Hop La Pitie Salpetriere, Publ Hosp Network Paris, Inst Myol, Dept Neuromyol, Paris, France
[4] Univ Cattolica Sacro Cuore, Rome, Italy
[5] Agostino Gemelli Univ Polyclin Fdn, Sci Inst Res & Hlth Care, Rome, Italy
[6] Med Univ Warsaw, Dept Neurol, Warsaw, Poland
[7] Vall dHebron Univ Hosp, Neurol Dept, Barcelona, Spain
[8] Uppsala Univ, Dept Med Sci, Clin Neurophysiol, Uppsala, Sweden
[9] Nice Univ Hosp Ctr, Nice, France
[10] Univ Hosp Cologne, Dept Neurol, Cologne, Germany
[11] Leiden Univ, Med Ctr, Neurol, Leiden, Netherlands
[12] Prescript Commun, Letchworth, England
[13] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England
关键词
autoantibodies; biomarkers; myasthenia gravis; ANTIACETYLCHOLINE RECEPTOR ANTIBODY; ACETYLCHOLINE-RECEPTOR; DISEASE SEVERITY; TITIN-ANTIBODIES; PROTEIN; MUSK; ASSOCIATION;
D O I
10.1111/ene.15565
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose Although myasthenia gravis (MG) is recognized as an immunoglobulin G autoantibody-mediated disease, the relationship between autoantibody levels and disease activity in MG is unclear. We sought to evaluate this landscape through systematically assessing the evidence, testing the impact of predefined variables on any relationship, and augmenting with expert opinion. Methods In October 2020, a forum of leading clinicians and researchers in neurology from across Europe (Expert Forum for Rare Autoantibodies in Neurology in Myasthenia Gravis) participated in a series of virtual meetings that took place alongside the conduct of a systematic literature review (SLR). Results Forty-two studies were identified meeting inclusion criteria. Of these, 10 reported some correlation between a patient's autoantibody level and disease severity. Generally, decreased autoantibody levels (acetylcholine receptor, muscle-specific kinase, and titin) were positively and significantly correlated with improvements in disease severity (Quantitative Myasthenia Gravis score, Myasthenia Gravis Composite score, Myasthenia Gravis Activities of Daily Living score, Myasthenia Gravis Foundation of America classification). Given the limited evidence, testing the impact of predefined variables was not feasible. Conclusions This first SLR to assess whether a correlation exists between autoantibody levels and disease activity in patients with MG has indicated a potential positive correlation, which could have clinical implications in guiding treatment decisions. However, in light of the limited and variable evidence, we cannot currently recommend routine clinical use of autoantibody level testing in this context. For now, patient's characteristics, clinical disease course, and laboratory data (e.g., autoantibody status, thymus histology) should inform management, alongside patient-reported outcomes. We highlight the need for future studies to reach more definitive conclusions on this relationship.
引用
收藏
页码:266 / 282
页数:17
相关论文
共 50 条
  • [41] Diabetes mellitus in patients with myasthenia gravis: a systematic review and meta-analysis
    Shao, Tianrui
    Lu, Jing
    Kang, Hailan
    Zhang, Yibin
    Lan, Tianye
    Wang, Jian
    ENDOCRINE, 2024, : 24 - 35
  • [42] Takotsubo syndrome in patients with myasthenia gravis: a systematic review of previously reported cases
    Devarajan Rathish
    Minuri Karalliyadda
    BMC Neurology, 19
  • [43] Takotsubo syndrome in patients with myasthenia gravis: a systematic review of previously reported cases
    Rathish, Devarajan
    Karalliyadda, Minuri
    BMC NEUROLOGY, 2019, 19 (01)
  • [44] Rituximab in AChR subtype of myasthenia gravis: systematic review
    Di Stefano, Vincenzo
    Lupica, Antonino
    Rispoli, Marianna Gabriella
    Di Muzio, Antonio
    Brighina, Filippo
    Rodolico, Carmelo
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2020, 91 (04): : 392 - 395
  • [45] Frequency of Autoimmune Diseases in Myasthenia Gravis: A Systematic Review
    Mao, Zhi-Feng
    Yang, Long-Xiu
    Mo, Xue-An
    Qin, Chao
    Lai, Yong-Rong
    He, Ning-Yu
    Li, Tong
    Hackett, Maree L.
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2011, 121 (03) : 121 - 129
  • [46] Myasthenia Gravis in pregnancy: Systematic review and case series
    Banner, Harrison
    Niles, Kirsten M.
    Ryu, Michelle
    Sermer, Mathew
    Bril, Vera
    Murphy, Kellie E.
    OBSTETRIC MEDICINE, 2022, 15 (02) : 108 - 117
  • [47] THE EPIDEMIOLOGY OF MYASTHENIA GRAVIS IN ARAB COUNTRIES: A SYSTEMATIC REVIEW
    Benamer, Hani T. S.
    Bredan, Amin
    MUSCLE & NERVE, 2015, 51 (01) : 144 - 145
  • [48] The humanistic burden of myasthenia gravis: A systematic literature review
    Gelinas, Deborah
    Parvin-Nejad, Sara
    Phillips, Glenn
    Cole, Caroline
    Hughes, Tom
    Silvestri, Nicholas
    Govindarajan, Raghav
    Jefferson, Matthew
    Campbell, Joanna
    Burnett, Heather
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2022, 437
  • [49] Perioperatives Management der Myasthenia gravis aus der Sicht der AnästhesistenAnesthetic management of patients with myasthenia gravis
    T. Brüssel
    Zeitschrift für Herz-, Thorax- und Gefäßchirurgie, 1998, 12 (6) : 271 - 275
  • [50] Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia gravis patients
    Hong, Yu
    Li, Hai-Feng
    Skeie, Geir Olve
    Romi, Fredrik
    Hao, Hong-Jun
    Zhang, Xu
    Gao, Xiang
    Owe, Jone Furlund
    Gilhus, Nils Erik
    JOURNAL OF NEUROIMMUNOLOGY, 2016, 298 : 51 - 57